This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Corydalis yanhusuo is a traditional Asian medicinal herb primarily utilized for its potent analgesic properties [PMID:34946576, PMID:32223481].
Background
Corydalis yanhusuo (also known as yanhusuo, yuanhu, yanhu, or xuanhu) is a member of the Papaveraceae family, with the dried tuber serving as the primary medicinal organ [PMID:37729733, PMID:35003289, PMID:38004347]. It is distributed in regions of China such as Zhe Jiang, Shaan Xi, and Jiang Su [PMID:40708495].
Traditional uses
Traditionally used across Asia to relieve pain, motivate blood and Qi circulation, and treat digestive system diseases [PMID:34946576, PMID:37729733, PMID:36681166]. Specific traditional applications include the treatment of headache, abdominal pain, and epigastric pain [PMID:32223481].
Active compounds
The herb contains over 160 compounds, including organic acids, volatile oils, amino acids, alcohols, and sugars [PMID:34946576, PMID:40708495]. The primary bioactive constituents are alkaloids (over 80 identified), categorized into protoberberine, aporphine, and opiate alkaloids [PMID:34946576, PMID:37729733]. Specific identified compounds include tetrahydropalmatine, corydaline, protopine, dehydrocorydaline, berberine, coptisine, and cavidine [PMID:20234973, PMID:34329130, PMID:40792414]. Polysaccharides (e.g., CYHSP-1 and CYHSP-2) are also present [PMID:40023428].
Mechanism of action
Analgesic effects are mediated through the inhibition of voltage-gated sodium channels [PMID:34329712] and the P2X3 receptor [PMID:39461390]. Other mechanisms include modulating neurotransmitters, ion channels, the HPA axis, and signaling pathways [PMID:37729733]. Specific compounds like yanhusanine J and tetrahydroberberine inhibit the NF-κB pathway [PMID:34839130, PMID:39238071], while others act as acetylcholinesterase (AChE) inhibitors [PMID:20234973, PMID:36758275]. Polysaccharides may regulate HPA-axis mediated microglia activation and 5-HT signaling via gut microbiota-derived short-chain fatty acids [PMID:40513699, PMID:38010856].
Clinical evidence
Evidence CPain Management
Used as an analgesic agent for various conditions including headache, migraine, chest pain, abdominal pain, low back pain, and neuropathic pain [PMID:32054304, PMID:32223481].
Evidence CDrug Addiction
Rhizoma Corydalis may be used to prevent relapse to chronic drug dependence [PMID:28807162].
Evidence DMyocardial Ischemia
Quaternary ammonium alkaloids show significant effects on myocardial ischemia [PMID:28647508]; total alkaloids in Shuangshen Ningxin Capsule improved left ventricular function in rat models [PMID:37951149].
Evidence DDepression-like behavior
Corydalis yanhusuo polysaccharides improved depression-like behaviors and ameliorated hippocampal damage in CUMS-induced mice models [PMID:40513699, PMID:38010856].
Evidence DPostmenopausal Osteoporosis
Tetrahydroberberine (THB) mitigated ovariectomy-induced bone loss by inhibiting RANKL-induced osteoclastogenesis in vitro and in vivo [PMID:39238071].
Evidence D
Safety & adverse effects
Processing and compatibility may alter the efficacy and safety of the herb [PMID:35003289]. No specific adverse effects are detailed in the provided abstracts, though the need for quality control is emphasized [PMID:32193434].
Evidence summary
The evidence is primarily based on review articles (Level C) and preclinical animal or in vitro studies (Level D). There is strong preclinical evidence for analgesic, anti-inflammatory, and neuroprotective effects, but high-level clinical trial data (Level A/B) is not provided in the abstracts.
PubMed sources
1.PMID: 34946576 (2021) — The Analgesic Properties of Corydalis yanhusuo. · Molecules (Basel, Switzerland)
2.PMID: 37729733 (2023) — The composition, pharmacological effects, related mechanisms and drug delivery of alkaloids from Corydalis yanhusuo. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
3.PMID: 32054304 (2020) — Effects of Herbal Medicines on Pain Management. · The American journal of Chinese medicine
4.PMID: 35003289 (2021) — Processing and Compatibility of Corydalis yanhusuo: Phytochemistry, Pharmacology, Pharmacokinetics, and Safety. · Evidence-based complementary and alternative medicine : eCAM
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
Dehydrocorydaline attenuated bleomycin-induced pulmonary fibrosis by inhibiting fibroblast activation in mouse models [PMID:40221718].
Evidence DPeripheral Nerve Injury
Tetrahydropalmatine (THP) ameliorated peripheral nerve regeneration by enhancing macrophage anti-inflammatory response in rats [PMID:39765002].
· Brain research
6.PMID: 39238071 (2024) — Tetrahydroberberine Prevents Ovariectomy-Induced Bone Loss by Inhibiting RANKL-Induced Osteoclastogenesis and Promoting Osteoclast Apoptosis. · Journal of agricultural and food chemistry
7.PMID: 28807162 (2017) — Chinese Herbal Medicine for the Treatment of Drug Addiction. · International review of neurobiology
8.PMID: 28647508 (2017) — Fingerprint-efficacy study of the quaternary alkaloids in Corydalis yanhusuo. · Journal of ethnopharmacology
9.PMID: 34839130 (2022) — 13,13a-seco-protoberberines from the tubers of Corydalis yanhusuo and their anti-inflammatory activity. · Phytochemistry
10.PMID: 20234973 (2011) — Acetylcholinesterase inhibitors from Corydalis yanhusuo. · Natural product research
11.PMID: 40221718 (2025) — Dehydrocorydaline attenuates bleomycin-induced pulmonary fibrosis by inhibiting fibroblast activation. · Respiratory research
12.PMID: 38910886 (2024) — Exploring the role of Chinese herbal medicine in the long-term management of postoperative ovarian endometriotic cysts: a systematic review and meta-analysis. · Frontiers in pharmacology
13.PMID: 38004347 (2023) — Integrating Full-Length and Second-Generation Transcriptomics to Reveal Differentially Expressed Genes Associated with the Development of Corydalis yanhusuo Tuber. · Life (Basel, Switzerland)
14.PMID: 39461390 (2025) — The analgesic effect and mechanism of the active components screening from Corydalis yanhusuo by P2X3 receptors. · Journal of ethnopharmacology
15.PMID: 36681166 (2023) — Gastroprotective action of the extract of Corydalis yanhusuo in Helicobacter pylori infection and its bioactive component, dehydrocorydaline. · Journal of ethnopharmacology
16.PMID: 37951149 (2024) — Investigation of the active ingredients of Shuangshen Ningxin Fomula and the mechanism underlying their protective effects against myocardial ischemia-reperfusion injury by mass spectrometric imaging. · Phytomedicine : international journal of phytotherapy and phytopharmacology
17.PMID: 40792414 (2025) — Investigating the Components Change of Steamed Corydalis yanhusuo via Mass Spectrometry Imaging, HS-GC-IMS, HPLC, and Network Pharmacology to Unveil Mechanism for Antichronic Atrophic Gastritis. · Biomedical chromatography : BMC
18.PMID: 28911575 (2016) — Recent progress on the traditional Chinese medicines that regulate the blood. · Journal of food and drug analysis
19.PMID: 39765002 (2025) — Tetrahydropalmatine ameliorates peripheral nerve regeneration by enhancing macrophage anti-inflammatory response. · International immunopharmacology
20.PMID: 36758275 (2023) — (±)-Yanhusuomide A, a pair of ornithine-fused benzylisoquinoline enantiomers from Corydalis yanhusuo. · Bioorganic chemistry
21.PMID: 32193434 (2020) — Quality Evaluation of Corydalis yanhusuo by High-Performance Liquid Chromatography Fingerprinting Coupled with Multicomponent Quantitative Analysis. · Scientific reports
22.PMID: 32223481 (2020) — Advances in phytochemical and modern pharmacological research of Rhizoma Corydalis. · Pharmaceutical biology
23.PMID: 35069636 (2021) — Peanut Rotation and Flooding Induce Rhizobacteriome Variation With Opposing Influences on the Growth and Medicinal Yield of Corydalis yanhusuo. · Frontiers in plant science
24.PMID: 40023428 (2025) — Structural characterization of Corydalis yanhusuo polysaccharides and its bioactivity in vitro. · International journal of biological macromolecules
25.PMID: 38876472 (2024) — Fu'cupping Physical Permeation-Enhancing Technique Enhances the Therapeutic Efficacy of Corydalis yanhusuo Gel Plaster. · Planta medica
26.PMID: 38010856 (2023) — Corydalis yanhusuo Polysaccharides Ameliorate Chronic Stress-Induced Depression in Mice through Gut Microbiota-Derived Short-Chain Fatty Acid Activation of 5-Hydroxytryptamine Signaling. · Journal of medicinal food
27.PMID: 40708495 (2025) — Ethnomedicine, Botany, Phytochemistry, Pharmacology, Pharmacokinetics, and Toxicity of Rhizoma Corydalis: A Systematic Review. · The American journal of Chinese medicine
28.PMID: 34329712 (2021) — Analgesic effect of the main components of Corydalis yanhusuo (yanhusuo in Chinese) is caused by inhibition of voltage gated sodium channels. · Journal of ethnopharmacology
29.PMID: 41220036 (2025) — Rotation of Corydalis yanhusuo with different crops enhances its quality and soil nutrients: a multi-dimensional analysis of rhizosphere microecology. · BMC plant biology